Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZIO-101 in Advanced Multiple Myeloma
NCT00303199Phase 2Completed
- Sponsor
- Alaunos Therapeutics
- Start
- Jan 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of darinaparsin in multiple myeloma (MM), sponsored by Alaunos Therapeutics. Started Jan 2006; status: completed.
02
Drugs
darinaparsin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00303199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303199.